Wall Street’s Not Spooked by Weight-Loss Drugs—Here’s What’s Really Sinking PepsiCo Stock

Weight-loss drugs aren’t killing PepsiCo’s stock – plunging sales and a worrying debt ratio tell the real story behind the beverage giant’s decline.

Palantir Surges, Crushes Earnings—Then Craters: What Spooked Investors?

Despite crushing earnings and 340% returns, Palantir’s stock nosedived 20% in a puzzling market reaction. What made investors run scared?